{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:42:21Z","timestamp":1794357741418,"version":"4.9.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272929"],"award-info":[{"award-number":["82272929"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272929"],"award-info":[{"award-number":["82272929"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272929"],"award-info":[{"award-number":["82272929"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272929"],"award-info":[{"award-number":["82272929"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272929"],"award-info":[{"award-number":["82272929"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272929"],"award-info":[{"award-number":["82272929"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272929"],"award-info":[{"award-number":["82272929"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>As a novel form of nonapoptotic cell death, ferroptosis is developing into a promising therapeutic target of dedifferentiating and therapy-refractory cancers. However, its application in pancreatic cancer is still unknown. In the preliminary research, we found that F-box and WD repeat domain-containing 7 (FBW7) inhibited the migration and proliferation of pancreatic cancer cells through its substrate c-Myc. We further found that another key substrate of FBW7, KLF5, could inhibit ferroptosis. Inhibiting KLF5 significantly enhances the cytotoxicity of oxaliplatin rather than other chemotherapy drugs. Mechanistically, we found that KLF5 inhibited the expression of heme oxygenase 1 (HMOX1) via repressing zinc finger E-box-binding homeobox 1 (ZEB1). Inhibition of KLF5 facilitated the cytotoxic effect of oxaliplatin via promoting ferroptosis. Oxaliplatin combined with KLF5 inhibitor significantly potentiated cell death in vitro and inhibited tumor growth in vivo compared with either treatment alone. These results reveal a critical role of KLF5 in sensitized chemotherapy of pancreatic cancer, and suggest that ferroptosis combined with platinum-based chemotherapy rather than gemcitabine-based chemotherapy is expected to bring better therapeutic effects.<\/jats:p>","DOI":"10.1038\/s41419-025-07330-8","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T17:57:18Z","timestamp":1737223038000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Inhibition of KLF5 promotes ferroptosis via the ZEB1\/HMOX1 axis to enhance sensitivity to oxaliplatin in cancer cells"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1396-2634","authenticated-orcid":false,"given":"Zheng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaxiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiangsheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5820-6843","authenticated-orcid":false,"given":"Wenhui","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenye","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0971-518X","authenticated-orcid":false,"given":"Yaolin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4696-8098","authenticated-orcid":false,"given":"Wenquan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0403-6580","authenticated-orcid":false,"given":"Liang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,18]]},"reference":[{"key":"7330_CR1","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41571-019-0281-6","volume":"17","author":"C Nevala-Plagemann","year":"2020","unstructured":"Nevala-Plagemann C, Hidalgo M, Garrido-Laguna I. From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer. Nat Rev Clin Oncol. 2020;17:108\u201323.","journal-title":"Nat Rev Clin Oncol"},{"key":"7330_CR2","doi-asserted-by":"publisher","first-page":"e214708","DOI":"10.1001\/jamanetworkopen.2021.4708","volume":"4","author":"L Rahib","year":"2021","unstructured":"Rahib L, Wehner MR, Matrisian LM, Nead KT. Estimated projection of US cancer incidence and death to 2040. JAMA Netw Open. 2021;4:e214708.","journal-title":"JAMA Netw Open"},{"key":"7330_CR3","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","volume":"369","author":"DD Von Hoff","year":"2013","unstructured":"Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. New Engl J Med. 2013;369:1691\u2013703.","journal-title":"New Engl J Med"},{"key":"7330_CR4","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","volume":"379","author":"T Conroy","year":"2018","unstructured":"Conroy T, Hammel P, Hebbar M, Ben Abdelghani M, Wei AC, Raoul JL, et al. FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer. New Engl J Med. 2018;379:2395\u2013406.","journal-title":"New Engl J Med"},{"key":"7330_CR5","first-page":"2650","volume":"9","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Liu M, Hu Q, Xu W, Liu W, Sun Q, et al. FGFBP1, a downstream target of the FBW7\/c-Myc axis, promotes cell proliferation and migration in pancreatic cancer. Am J Cancer Res. 2019;9:2650\u201364.","journal-title":"Am J Cancer Res"},{"key":"7330_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nrc2290","volume":"8","author":"M Welcker","year":"2008","unstructured":"Welcker M, Clurman BE. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer. 2008;8:83\u201393.","journal-title":"Nat Rev Cancer"},{"key":"7330_CR7","doi-asserted-by":"publisher","first-page":"18858","DOI":"10.1074\/jbc.M109.099440","volume":"285","author":"N Liu","year":"2010","unstructured":"Liu N, Li H, Li S, Shen M, Xiao N, Chen Y, et al. The Fbw7\/human CDC4 tumor suppressor targets proproliferative factor KLF5 for ubiquitination and degradation through multiple phosphodegron motifs. J Biol Chem. 2010;285:18858\u201367.","journal-title":"J Biol Chem"},{"key":"7330_CR8","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/sj.cr.7290271","volume":"15","author":"AM Ghaleb","year":"2005","unstructured":"Ghaleb AM, Nandan MO, Chanchevalap S, Dalton WB, Hisamuddin IM, Yang VW. Kr\u00fcppel-like factors 4 and 5: the yin and yang regulators of cellular proliferation. Cell Res. 2005;15:92\u20136.","journal-title":"Cell Res"},{"key":"7330_CR9","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrc3582","volume":"13","author":"MP Tetreault","year":"2013","unstructured":"Tetreault MP, Yang Y, Katz JP. Kr\u00fcppel-like factors in cancer. Nat Rev Cancer. 2013;13:701\u201313.","journal-title":"Nat Rev Cancer"},{"key":"7330_CR10","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/s41588-021-00859-2","volume":"53","author":"Z Wu","year":"2021","unstructured":"Wu Z, Zhou J, Zhang X, Zhang Z, Xie Y, Liu JB, et al. Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependence. Nat Genet. 2021;53:881\u201394.","journal-title":"Nat Genet"},{"key":"7330_CR11","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1158\/0008-5472.CAN-21-2778","volume":"82","author":"R Wei","year":"2022","unstructured":"Wei R, Zhou Y, Li C, Rychahou P, Zhang S, Titlow WB, et al. Ketogenesis attenuates KLF5-dependent production of CXCL12 to overcome the immunosuppressive tumor microenvironment in colorectal cancer. Cancer Res. 2022;82:1575\u201388.","journal-title":"Cancer Res"},{"key":"7330_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21976-w","volume":"12","author":"B Zhang","year":"2021","unstructured":"Zhang B, Li Y, Wu Q, Xie L, Barwick B, Fu C, et al. Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer. Nat Commun. 2021;12:1714.","journal-title":"Nat Commun"},{"key":"7330_CR13","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1158\/0008-5472.CAN-20-0652","volume":"81","author":"S Ma","year":"2021","unstructured":"Ma S, Zhou B, Yang Q, Pan Y, Yang W, Freedland SJ, et al. A transcriptional regulatory loop of master regulator transcription factors, PPARG, and fatty acid synthesis promotes esophageal adenocarcinoma. Cancer Res. 2021;81:1216\u201329.","journal-title":"Cancer Res"},{"key":"7330_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abk1538","volume":"8","author":"J Mooz","year":"2022","unstructured":"Mooz J, Riegel K, Ps H, Sadanandam A, Marini F, Klein M, et al. ARAF suppresses ERBB3 expression and metastasis in a subset of lung cancers. Sci Adv. 2022;8:eabk1538.","journal-title":"Sci Adv"},{"key":"7330_CR15","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.cell.2016.01.009","volume":"164","author":"CJ David","year":"2016","unstructured":"David CJ, Huang YH, Chen M, Su J, Zou Y, Bardeesy N, et al. TGF-\u03b2 tumor suppression through a lethal EMT. Cell. 2016;164:1015\u201330.","journal-title":"Cell"},{"key":"7330_CR16","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1158\/2159-8290.CD-20-0519","volume":"11","author":"J Li","year":"2021","unstructured":"Li J, Yuan S, Norgard RJ, Yan F, Sun YH, Kim IK, et al. Epigenetic and transcriptional control of the epidermal growth factor receptor regulates the tumor immune microenvironment in pancreatic cancer. Cancer Discov. 2021;11:736\u201353.","journal-title":"Cancer Discov"},{"key":"7330_CR17","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.18632\/aging.102096","volume":"11","author":"Y Li","year":"2019","unstructured":"Li Y, Kong R, Chen H, Zhao Z, Li L, Li J, et al. Overexpression of KLF5 is associated with poor survival and G1\/S progression in pancreatic cancer. Aging. 2019;11:5035\u201357.","journal-title":"Aging"},{"key":"7330_CR18","doi-asserted-by":"publisher","first-page":"12642","DOI":"10.1111\/jcmm.15832","volume":"24","author":"W Xia","year":"2020","unstructured":"Xia W, Bai H, Deng Y, Yang Y. PLA2G16 is a mutant p53\/KLF5 transcriptional target and promotes glycolysis of pancreatic cancer. J Cell Mol Med. 2020;24:12642\u201355.","journal-title":"J Cell Mol Med"},{"key":"7330_CR19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","volume":"19","author":"JP Friedmann Angeli","year":"2019","unstructured":"Friedmann Angeli JP, Krysko DV, Conrad M. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat Rev Cancer. 2019;19:405\u201314.","journal-title":"Nat Rev Cancer"},{"key":"7330_CR20","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.tips.2017.02.005","volume":"38","author":"JPF Angeli","year":"2017","unstructured":"Angeli JPF, Shah R, Pratt DA, Conrad M. Ferroptosis inhibition: mechanisms and opportunities. Trends Pharm Sci. 2017;38:489\u201398.","journal-title":"Trends Pharm Sci"},{"key":"7330_CR21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171:273\u201385.","journal-title":"Cell"},{"key":"7330_CR22","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202051532","volume":"22","author":"T Nakamura","year":"2021","unstructured":"Nakamura T, Ogawa M, Kojima K, Takayanagi S, Ishihara S, Hattori K, et al. The mitochondrial Ca(2+) uptake regulator, MICU1, is involved in cold stress-induced ferroptosis. EMBO Rep. 2021;22:e51532.","journal-title":"EMBO Rep"},{"key":"7330_CR23","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.cmet.2021.05.016","volume":"33","author":"E Dierge","year":"2021","unstructured":"Dierge E, Debock E, Guilbaud C, Corbet C, Mignolet E, Mignard L, et al. Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects. Cell Metab. 2021;33:1701\u201315.e5.","journal-title":"Cell Metab"},{"key":"7330_CR24","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-020-2732-8","volume":"585","author":"Y Zou","year":"2020","unstructured":"Zou Y, Henry WS, Ricq EL, Graham ET, Phadnis VV, Maretich P, et al. Plasticity of ether lipids promotes ferroptosis susceptibility and evasion. Nature. 2020;585:603\u20138.","journal-title":"Nature"},{"key":"7330_CR25","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature23007","volume":"547","author":"VS Viswanathan","year":"2017","unstructured":"Viswanathan VS, Ryan MJ, Dhruv HD, Gill S, Eichhoff OM, Seashore-Ludlow B, et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. 2017;547:453\u20137.","journal-title":"Nature"},{"key":"7330_CR26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","volume":"551","author":"MJ Hangauer","year":"2017","unstructured":"Hangauer MJ, Viswanathan VS, Ryan MJ, Bole D, Eaton JK, Matov A, et al. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Nature. 2017;551:247\u201350.","journal-title":"Nature"},{"key":"7330_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41586-020-2623-z","volume":"585","author":"JM Ubellacker","year":"2020","unstructured":"Ubellacker JM, Tasdogan A, Ramesh V, Shen B, Mitchell EC, Martin-Sandoval MS, et al. Lymph protects metastasizing melanoma cells from ferroptosis. Nature. 2020;585:113\u20138.","journal-title":"Nature"},{"key":"7330_CR28","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.molcel.2021.12.001","volume":"82","author":"R Rodriguez","year":"2022","unstructured":"Rodriguez R, Schreiber SL, Conrad M. Persister cancer cells: Iron addiction and vulnerability to ferroptosis. Mol Cell. 2022;82:728\u201340.","journal-title":"Mol Cell"},{"key":"7330_CR29","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"W Wang","year":"2019","unstructured":"Wang W, Green M, Choi JE, Gij\u00f3n M, Kennedy PD, Johnson JK, et al. CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy. Nature. 2019;569:270\u20134.","journal-title":"Nature"},{"key":"7330_CR30","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/nrc2960","volume":"10","author":"D Vigil","year":"2010","unstructured":"Vigil D, Cherfils J, Rossman KL, Der CJ. Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy? Nat Rev Cancer. 2010;10:842\u201357.","journal-title":"Nat Rev Cancer"},{"key":"7330_CR31","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S1535-6108(03)00050-3","volume":"3","author":"S Dolma","year":"2003","unstructured":"Dolma S, Lessnick SL, Hahn WC, Stockwell BR. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell. 2003;3:285\u201396.","journal-title":"Cancer Cell"},{"key":"7330_CR32","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.chembiol.2008.02.010","volume":"15","author":"WS Yang","year":"2008","unstructured":"Yang WS, Stockwell BR. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem Biol. 2008;15:234\u201345.","journal-title":"Chem Biol"},{"key":"7330_CR33","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nrc.2016.66","volume":"16","author":"A Makohon-Moore","year":"2016","unstructured":"Makohon-Moore A, Iacobuzio-Donahue CA. Pancreatic cancer biology and genetics from an evolutionary perspective. Nat Rev Cancer. 2016;16:553\u201365.","journal-title":"Nat Rev Cancer"},{"key":"7330_CR34","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1158\/0008-5472.CAN-16-1979","volume":"77","author":"S Zhu","year":"2017","unstructured":"Zhu S, Zhang Q, Sun X, Zeh HJ 3rd, Lotze MT, et al. HSPA5 regulates ferroptotic cell death in cancer cells. Cancer Res. 2017;77:2064\u201377.","journal-title":"Cancer Res"},{"key":"7330_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20154-8","volume":"11","author":"E Dai","year":"2020","unstructured":"Dai E, Han L, Liu J, Xie Y, Zeh HJ, Kang R, et al. Ferroptotic damage promotes pancreatic tumorigenesis through a TMEM173\/STING-dependent DNA sensor pathway. Nat Commun. 2020;11:6339.","journal-title":"Nat Commun"},{"key":"7330_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24859-2","volume":"12","author":"DM Kremer","year":"2021","unstructured":"Kremer DM, Nelson BS, Lin L, Yarosz EL, Halbrook CJ, Kerk SA, et al. GOT1 inhibition promotes pancreatic cancer cell death by ferroptosis. Nat Commun. 2021;12:4860.","journal-title":"Nat Commun"},{"key":"7330_CR37","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1126\/science.aaw9872","volume":"368","author":"Badgley MA","year":"2020","unstructured":"Badgley MA, Kremer DM, Maurer HC, DelGiorno KE, Lee HJ, Purohit V, et al. Cysteine depletion induces pancreatic tumor ferroptosis in mice. Science. 2020;368:85\u20139.","journal-title":"Science"},{"key":"7330_CR38","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.cell.2006.01.040","volume":"124","author":"J Moffat","year":"2006","unstructured":"Moffat J, Grueneberg DA, Yang X, Kim SY, Kloepfer AM, Hinkle G, et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell. 2006;124:1283\u201398.","journal-title":"Cell"},{"key":"7330_CR39","doi-asserted-by":"publisher","first-page":"e12456","DOI":"10.1111\/cpr.12456","volume":"51","author":"Q Hu","year":"2018","unstructured":"Hu Q, Qin Y, Xiang J, Liu W, Xu W, Sun Q, et al. dCK negatively regulates the NRF2\/ARE axis and ROS production in pancreatic cancer. Cell Prolif. 2018;51:e12456.","journal-title":"Cell Prolif"},{"key":"7330_CR40","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s43018-020-00121-4","volume":"1","author":"NG Steele","year":"2020","unstructured":"Steele NG, Carpenter ES, Kemp SB, Sirihorachai VR, The S, Delrosario L, et al. Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer. Nat Cancer. 2020;1:1097\u2013112.","journal-title":"Nat Cancer"},{"key":"7330_CR41","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41588-022-01134-8","volume":"54","author":"WL Hwang","year":"2022","unstructured":"Hwang WL, Jagadeesh KA, Guo JA, Hoffman HI, Yadollahpour P, Reeves JW, et al. Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment. Nat Genet. 2022;54:1178\u201391.","journal-title":"Nat Genet"},{"key":"7330_CR42","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/embj.201592404","volume":"35","author":"GR Diaferia","year":"2016","unstructured":"Diaferia GR, Balestrieri C, Prosperini E, Nicoli P, Spaggiari P, Zerbi A, et al. Dissection of transcriptional and cis-regulatory control of differentiation in human pancreatic cancer. EMBO J. 2016;35:595\u2013617.","journal-title":"EMBO J"},{"key":"7330_CR43","doi-asserted-by":"publisher","first-page":"D571","DOI":"10.1093\/nar\/gkac935","volume":"51","author":"N Zhou","year":"2023","unstructured":"Zhou N, Yuan X, Du Q, Zhang Z, Shi X, Bao J, et al. FerrDb V2: update of the manually curated database of ferroptosis regulators and ferroptosis-disease associations. Nucleic Acids Res. 2023;51:D571\u2013d82.","journal-title":"Nucleic Acids Res"},{"key":"7330_CR44","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","volume":"35","author":"B Hassannia","year":"2019","unstructured":"Hassannia B, Vandenabeele P, Vanden Berghe T. Targeting ferroptosis to iron out cancer. Cancer Cell. 2019;35:830\u201349.","journal-title":"Cancer Cell"},{"key":"7330_CR45","doi-asserted-by":"crossref","first-page":"D87","DOI":"10.1093\/nar\/gkaa516","volume":"48","author":"O Fornes","year":"2020","unstructured":"Fornes O, Castro-Mondragon JA, Khan A, van der Lee R, Zhang X, Richmond PA, et al. JASPAR 2020: update of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2020;48:D87\u2013d92.","journal-title":"Nucleic Acids Res"},{"key":"7330_CR46","doi-asserted-by":"publisher","first-page":"6742","DOI":"10.1002\/anie.201201562","volume":"51","author":"Y Min","year":"2012","unstructured":"Min Y, Mao CQ, Chen S, Ma G, Wang J, Liu Y. Combating the drug resistance of cisplatin using a platinum prodrug based delivery system. Angew Chem Int Edn. 2012;51:6742\u20137.","journal-title":"Angew Chem Int Edn"},{"key":"7330_CR47","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1158\/0008-5472.CAN-18-3855","volume":"79","author":"B Daher","year":"2019","unstructured":"Daher B, Parks SK, Durivault J, Cormerais Y, Baidarjad H, Tambutte E, et al. Genetic ablation of the cystine transporter xCT in PDAC cells inhibits mTORC1, growth, survival, and tumor formation via nutrient and oxidative stresses. Cancer Res. 2019;79:3877\u201390.","journal-title":"Cancer Res"},{"key":"7330_CR48","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"7330_CR49","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/jama.2021.13027","volume":"326","author":"W Park","year":"2021","unstructured":"Park W, Chawla A, O\u2019Reilly EM. Pancreatic cancer: a review. Jama. 2021;326:851\u201362.","journal-title":"Jama"},{"key":"7330_CR50","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","volume":"364","author":"T Conroy","year":"2011","unstructured":"Conroy T, Desseigne F, Ychou M, Bouch\u00e9 O, Guimbaud R, B\u00e9couarn Y, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. New Engl J Med. 2011;364:1817\u201325.","journal-title":"New Engl J Med"},{"key":"7330_CR51","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41586-019-1426-6","volume":"572","author":"J Wu","year":"2019","unstructured":"Wu J, Minikes AM, Gao M, Bian H, Li Y, Stockwell BR, et al. Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling. Nature. 2019;572:402\u20136.","journal-title":"Nature"},{"key":"7330_CR52","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","volume":"593","author":"C Mao","year":"2021","unstructured":"Mao C, Liu X, Zhang Y, Lei G, Yan Y, Lee H, et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature. 2021;593:586\u201390.","journal-title":"Nature"},{"key":"7330_CR53","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1158\/0008-5472.CAN-21-3230","volume":"82","author":"X Wang","year":"2022","unstructured":"Wang X, Li Y, Li Z, Lin S, Wang H, Sun J, et al. Mitochondrial calcium uniporter drives metastasis and confers a targetable cystine dependency in pancreatic cancer. Cancer Res. 2022;82:2254\u201368.","journal-title":"Cancer Res"},{"key":"7330_CR54","doi-asserted-by":"publisher","first-page":"445","DOI":"10.4143\/crt.2016.572","volume":"50","author":"J Guo","year":"2018","unstructured":"Guo J, Xu B, Han Q, Zhou H, Xia Y, Gong C, et al. Ferroptosis: a novel anti-tumor action for cisplatin. Cancer Res Treat. 2018;50:445\u201360.","journal-title":"Cancer Res Treat"},{"key":"7330_CR55","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41422-019-0263-3","volume":"30","author":"G Lei","year":"2020","unstructured":"Lei G, Zhang Y, Koppula P, Liu X, Zhang J, Lin SH, et al. The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression. Cell Res. 2020;30:146\u201362.","journal-title":"Cell Res"},{"key":"7330_CR56","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.canlet.2017.12.025","volume":"416","author":"LC Chang","year":"2018","unstructured":"Chang LC, Chiang SK, Chen SE, Yu YL, Chou RH, Chang WC. Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis. Cancer Lett. 2018;416:124\u201337.","journal-title":"Cancer Lett"},{"key":"7330_CR57","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1172\/JCI99032","volume":"128","author":"B Hassannia","year":"2018","unstructured":"Hassannia B, Wiernicki B, Ingold I, Qu F, Van Herck S, Tyurina YY, et al. Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma. J Clin Investig. 2018;128:3341\u201355.","journal-title":"J Clin Investig"},{"key":"7330_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202206798","volume":"10","author":"C Zheng","year":"2023","unstructured":"Zheng C, Zhang B, Li Y, Liu K, Wei W, Liang S, et al. Donafenib and GSK-J4 synergistically induce ferroptosis in liver cancer by upregulating HMOX1 expression. Adv Sci. 2023;10:e2206798.","journal-title":"Adv Sci"},{"key":"7330_CR59","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/hep.28251","volume":"63","author":"X Sun","year":"2016","unstructured":"Sun X, Ou Z, Chen R, Niu X, Chen D, Kang R, et al. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology. 2016;63:173\u201384.","journal-title":"Hepatology"},{"key":"7330_CR60","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1096\/fasebj.13.13.1800","volume":"13","author":"DM Suttner","year":"1999","unstructured":"Suttner DM, Dennery PA. Reversal of HO-1 related cytoprotection with increased expression is due to reactive iron. FASEB J. 1999;13:1800\u20139.","journal-title":"FASEB J"},{"key":"7330_CR61","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/ncb3513","volume":"19","author":"AM Krebs","year":"2017","unstructured":"Krebs AM, Mitschke J, Lasierra Losada M, Schmalhofer O, Boerries M, Busch H, et al. The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. Nat Cell Biol. 2017;19:518\u201329.","journal-title":"Nat Cell Biol"},{"key":"7330_CR62","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.7150\/ijbs.71520","volume":"18","author":"X Wang","year":"2022","unstructured":"Wang X, Liu M, Chu Y, Liu Y, Cao X, Zhang H, et al. O-GlcNAcylation of ZEB1 facilitated mesenchymal pancreatic cancer cell ferroptosis. Int J Biol Sci. 2022;18:4135\u201350.","journal-title":"Int J Biol Sci"},{"key":"7330_CR63","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.1128\/MCB.00787-13","volume":"33","author":"B Zhang","year":"2013","unstructured":"Zhang B, Zhang Z, Xia S, Xing C, Ci X, Li X, et al. KLF5 activates microRNA 200 transcription to maintain epithelial characteristics and prevent induced epithelial-mesenchymal transition in epithelial cells. Mol Cell Biol. 2013;33:4919\u201335.","journal-title":"Mol Cell Biol"},{"key":"7330_CR64","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","volume":"21","author":"J Yang","year":"2020","unstructured":"Yang J, Antin P, Berx G, Blanpain C, Brabletz T, Bronner M, et al. Guidelines and definitions for research on epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2020;21:341\u201352.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7330_CR65","doi-asserted-by":"crossref","unstructured":"Schwab A, Rao Z, Zhang J, Gollowitzer A, Siebenk\u00e4s K, Bindel N, et al. Zeb1 mediates EMT\/plasticity-associated ferroptosis sensitivity in cancer cells by regulating lipogenic enzyme expression and phospholipid composition. Nat Cell Biol. 2024;26:1470\u201381.","DOI":"10.1038\/s41556-024-01464-1"},{"key":"7330_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05384-6","volume":"13","author":"Q Dang","year":"2022","unstructured":"Dang Q, Sun Z, Wang Y, Wang L, Liu Z, Han X. Ferroptosis: a double-edged sword mediating immune tolerance of cancer. Cell Death Dis. 2022;13:925.","journal-title":"Cell Death Dis"},{"key":"7330_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2022.100916","volume":"66","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wu X, Ren Z, Li Y, Zou W, Chen J, et al. Overcoming cancer chemotherapy resistance by the induction of ferroptosis. Drug Resist Updat. 2023;66:100916.","journal-title":"Drug Resist Updat"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07330-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07330-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07330-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T18:49:36Z","timestamp":1737226176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07330-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,18]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7330"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07330-8","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,18]]},"assertion":[{"value":"1 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. The clinical tissue samples were obtained from patients diagnosed with pancreatic cancer at Zhongshan Hospital, Fudan University (ZSHFU). The patients\u2019 consent and approval from the Institutional Research Ethics Committee of ZSHFU were obtained (Batch number:1310128-2). The protocol of animal assays was approved by the Committee on the Ethics of Animal Experiments of Fudan University and conformed to the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (Batch number:2023-271). Informed consent was obtained from all participants. No identifiable images from human research participants were included.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"28"}}